Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,338 | -16,444 | -12,200 | -7,541 | -3,647 |
| Depreciation Amortization | 152 | 481 | 324 | 164 | 62 |
| Accounts payable and accrued liabilities | -234 | 841 | 648 | 391 | 380 |
| Other Working Capital | -259 | 400 | 126 | -370 | -453 |
| Other Operating Activity | 335 | -265 | -43 | -53 | -225 |
| Operating Cash Flow | $-4,344 | $-14,987 | $-11,145 | $-7,409 | $-3,883 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -12 | -8 | -2 | -1 |
| Purchase Of Investment | -1,542 | -20,504 | -20,504 | -17,462 | -5,201 |
| Sale Of Investment | 4,550 | 4,102 | 950 | 450 | N/A |
| Investing Cash Flow | $3,008 | $-16,414 | $-19,562 | $-17,014 | $-5,202 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 210 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -105 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $105 | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 7,401 | 38,802 | 38,802 | 38,802 | 38,802 |
| End Cash Position | 6,170 | 7,401 | 8,095 | 14,379 | 29,717 |
| Net Cash Flow | $-1,231 | $-31,401 | $-30,707 | $-24,423 | $-9,085 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,344 | -14,987 | -11,145 | -7,409 | -3,883 |
| Capital Expenditure | N/A | -12 | -8 | -2 | -1 |
| Free Cash Flow | -4,344 | -14,999 | -11,153 | -7,411 | -3,884 |